Advances in the cancer treatment space have renewed hope for breakthroughs with personalized cancer vaccines (often also called personalized immunotherapies). Despite the promise, experience shows that there are many challenges that innovators need to overcome from a development, regulatory, and chemistry, manufacturing, and controls perspective.
